Targeted Strategies for Today's Evolving Markets

MissionIR Blog

EpiCept Corp. (EPCT) Starts Presentation at 15th Annual BIO CEO & Investor Conference

EpiCept is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products to treat pain and cancer. The company’s cancer product, Ceplene, has been approved in the European Union, and its balanced pipeline of three major clinical product candidates includes AmiKet, Crolibulin and Azixa. EpiCept’s headquarters are located in Tarrytown, N.Y. For more information, visit the company’s Web site at

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit

Let us hear your thoughts below:

This entry was posted in BIO Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *